We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PTX market cap is 46.71M. The company's latest EPS is AUD -0.0087 and P/E is -6.90.
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 1.65M | 1.08M | 1.24M | 1.89M | 2.43M |
Operating Income | -3.9M | -3.42M | -4.19M | -5.21M | -7.46M |
Net Income | -3.8M | -3.32M | -4.15M | -5.12M | -7.01M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 15.01M | 12.07M | 20.97M | 17.62M | 28.11M |
Total Liabilities | 686k | 884k | 540k | 856k | 2.03M |
Total Equity | 14.32M | 11.19M | 20.43M | 16.76M | 26.08M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -4.2M | -2.32M | -3.97M | -4.31M | -6.19M |
Investing | N/A | N/A | -2k | -4k | N/A |
Financing | 8.37M | N/A | 12.75M | 428k | -172k |
Market Cap | 46.71M |
Price to Earnings Ratio | -6.90 |
Price to Sales Ratio | 20 |
Price to Cash Ratio | 8.22 |
Price to Book Ratio | 1.85 |
Dividend Yield | - |
Shares Outstanding | 805.32M |
Average Volume (1 week) | 624.47k |
Average Volume (1 Month) | 702.11k |
52 Week Change | -38.30% |
52 Week High | 0.105 |
52 Week Low | 0.044 |
Spread (Intraday) | 0 (1.69%) |
Company Name | Prescient Therapeutics Limited |
Address |
level 4 melbourne, victoria 3205 |
Website | https://www.ptxtherapeutics.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions